Enzyme activities along the kynurenine pathway in mice

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 497-510

  Allegri, Graziella ^a   Ragazzi, Eugenio ^a   Bertazzo, Antonella ^a   Costa, Carlo V L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYANTHRANILATE 3,4 DIOXYGENASE; AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE; CARBOXYLYASE; HEMATIN; HOLOENZYME; INDOLE 2,3 DIOXYGENASE; INTESTINE ENZYME; KIDNEY ENZYME; KYNURENINASE; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; KYNURENINE AMINOTRANSFERASE; LIVER ENZYME; SUPEROXIDE DISMUTASE; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; INTESTINE; KIDNEY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM;

3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE; ANIMALS; DIOXYGENASES; INTESTINE, SMALL; KIDNEY; KYNURENINE; KYNURENINE 3-MONOOXYGENASE; LIVER; MALE; MICE; MIXED FUNCTION OXYGENASES; OXYGENASES; SUPEROXIDE DISMUTASE; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

ANIMALIA;

EID: 1042291124     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (73)

1. L. Musajo and C.A. Benassi, Aspects of disorders of the kynurenine pathway of tryptophan metabolism in man, Adv. Clin. Chem. 7, 63-135 (1964).
2. F.M. Chiancone, Enzymes of the tryptophan → nicotinic acid pathway, in: Newer methods of nutritional biochemistry, edited by A.A. Albanese, Vol. 2 (Academic Press, New York, 1965), pp. 249-284.
3. J.M. Price, R.R. Brown, N. Yess, Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites, Adv. Metab. Disorders 2, 159-225 (1965).
4. H. Wolf, Studies on tryptophan metabolism in man, Scand. J. Clin. Lab. Invest. Suppl. No 136: 1-186, 1974.
5. R. Schwarcz, F. Du, W. Schmidt, W.A. Turski, J.B. Gramsbergen, E. Okuno, R.C. Roberts, Kynurenic acid: a potential pathogen in brain disorders, Ann. N.Y. Acad. Sci. 648, 140-153 (1992).
6. R. Schwarcz, Metabolism and function of brain kynurenines, Biochem. Soc. Trans. 21, 77-82 (1993).
7. M.P. Heyes, Metabolism and neuropathologic significance of quinolinic acid and kynurenic acid, Biochem. Soc. Trans. 21, 83-89 (1993).
8. F. Moroni, G. Lombardi, V. Carlà, G. Moneti, The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain, Brain Res. 295, 352-355 (1984).
9. D.H. Munn, M. Zohu, J.T. Attwood, I. Bondarev, S.J. Conway, B. Marshall, C. Brown, A.L. Mellor. Prevention of allogenic fetal rejection by tryptophan catabolism, Science 281, 1191-1193 (1998).
10. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, A.L. Mellor, Inhibition of T cell proliferation by macrophage tryptophan catabolism, J. Exp. Med. 189, 1363-1372 (1999).
11. F. Hirata and O. Hayaishi, Studies on indoleamine 2,3-dioxygenase. I Superoxide anion as substrate. J. Biol. Chem. 250, 5960-5966 (1975).
12. T. Ohnishi, F. Hirata, O. Hayaishi, Indoleamine 2,3-dioxygenase. Potassium superoxide as substrate. J. Biol. Chem. 252, 4643-4647 (1977).
13. W.E. Knox and V.H. Auerback, The hormonal control of tryptophan peroxidase in the rat, J. Biol. Chem. 214, 307-313 (1955).
14. W.E. Knox, The regulation of tryptophan pyrrolase activity by tryptophan, Adv. Enzyme Regul. 4, 287-297 (1966).
15. K. Altman and O. Greengard, Correlation of kynurenine excretion with liver tryptophan pyrrolase levels in disease and after hydrocortisone induction, J. Clin. Invest. 45, 1527-1534 (1966).
16. Y. Watanabe, M. Fujiwara, R. Yoshida, O. Hayaishi, Stereospecificity of hepatic L-tryptophan 2,3-dioxygenase, Biochem. J. 189, 393-405 (1980).
17. C.B. Monroe, Induction of tryptophan oxigenase and tyrosine aminotransferase in mice, Am. J. Physiol. 214, 1410-1414 (1968).
18. J. Hvitfelt and R.S. Santti, Tryptophan pyrrolase in the liver of guinea pig: The absence of hydrocortisone induction, Biochim. Biophys. Acta 258, 358-365 (1972).
19. A. A-B. Badawy and M. Evans, Guinea-pig liver tryptophan pyrrolase. Absence of detectable apoenzyme activity and of hormonal induction by cortisol and possible regulation by tryptophan, Biochem. J. 138, 445-451 (1974).
20. J.N. Brown and C.L. Dodgen, Fish liver tryptophan pyrrolase: The apparent absence of both hormonal and substrate induction, Biochim. Biophys. Acta 165, 463-469 (1968).
21. R.J. Johnson and L.A. Dyer, Effect of orally administered tryptophan on tryptophan pyrrolase activity in ovine and bovine, Life Sci. 5, 1121 -1124 (1966).
22. K.L. Baughman and J.M. Franz, Control of tryptophan oxygenase and formamidase activity in the gerbil, Int. J. Biochem. 2, 201-211 (1971).
23. M. Spiegel, Tryptophan pyrrolase activity in the liver of adult rana pipiens, Biol. Bull. 121, 547-553 (1961).
24. J.E. Leklem, J. Woodford and R.R. Brown, Comparative tryptophan metabolism in cats and rats. Comp. Biochem. Physiol. 31, 95-109 (1969).
25. A. A-B. Badawy and M. Evans, Animal liver tryptophan pyrrolases. Absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicity, Biochem. J. 158, 79-88 (1976).
26. O. Takikawa, R. Yoshida, R. Kido, and O. Hayaishi, Tryptophan degradation in mice initiated by indoleamine-2,3-dioxygenase, J. Biol. Chem. 261, 3648-3653 (1986).
27. R. Yoshida, T. Nukiwa, Y. Watanabe, M. Fujiwara, F. Hirata, O. Hayaishi, Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice, Arch. Biochem. Biophys. 203, 343-351 (1980).
28. R. Yoshida, J. Imanishi, T. Oku, T. Kishida, O. Hayaishi, Induction of pulmonary indoleamine 2,3-dioxygenase by interferon, Proc. Natl. Acad. Sci. USA, 78, 129-132 (1981).
29. R. Yoshida, T. Oku, J. Imanishi, T. Kishida, O. Hayaishi, Interferon: a mediator of indoleamine 2,3-dioxygenase induction by lipopolysaccharide, poly(l) poly(C) and pokeweed mitogen in mouse lung, Arch. Biochem. Biophys. 249, 596-604 (1986).
30. R. Yoshida, and O. Hayaishi, Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide, Proc. Natl. Acad. Sci. USA 75, 3998-4000 (1978).
31. R. Yoshida, Y. Urade, K. Nakata, Y. Watanabe, O. Hayaishi, Specific induction of indoleamine 2,3-dioxygenase by bacterial lipolysaccharide in the mouse lung, Arch. Biochem. Biophys. 212, 629-637 (1981).
32. R. Yoshida, Y. Urade, M. Tokuda, and O. Hayaishi, Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection, Proc. Natl. Acad. Sci. USA 76, 4084-4086 (1979).
33. F.T. DeCastro, J.M. Price, and R.R. Brown, Reduced triphosphopyridine- nucleotide requirement for the enzymatic formation of 3-hydroxykynurenine from L-kynurenine, J. Am. Chem. Soc. 78, 2904-2905 (1956).
34. M. Mason, C.P. Berg, Metabolism of D- and L-tryptophan and D- and L-kynurenine by liver and kidney preparations, J. Biol. Chem. 195, 515-524 (1952).
35. O. Wiss, Der enzymatische Abbau des Kynurenins in tierischen Organismus, Hoppe-Seyler's Z. Physiol. Chem. 293, 106-121 (1953).
36. 6 in this process, Biokhimya 14, 163-179 (1949).
37. Y. Kotake and Y.M. Nakayama, Über die Anthranilsäurebildung aus Kynurenin durch Organsaft, Hoppe-Seyler's Z. Physiol. Chem. 270, 76-83 (1941).
38. O. Wiss, and H. Fuchs, Über den Abbau von Kynurenin, Oxykynurenin und verwandten Substanzen durch Rattenleberenzym, Experientia (Basel), 6, 472-473 (1950).
39. Y. Nishizuka, A. Ichiyama, R.K. Gholson, O. Hayaishi, Studies on the metabolism of the benzene ring of tryptophan in mammalian tissues I. Enzymatic formation of glutaric acid from 3-hydroxyanthranilic acid, J. Biol. Chem. 240, 733-739 (1965).
40. A.H. Bokman, B.S. Schweigert, 3-Hydroxyanthranilic acid metabolism IV. Spectrophotometric evidence for the formation of an intermediate, Arch. Biochem. 33, 270-273 (1951).
41. O. Wiss, Die oxidative Spaltung der 3-Oxyanthranilsäure, Z. Naturforsch. 9B, 740-741 (1954).
42. A. Ichiyama, S. Nakamura, H. Kawai, T. Honjo, Y. Nishizuka, O. Hayaishi, S. Senoh, Studies on the metabolism of the benzene ring of tryptophan in mammalian tissues II. Enzymatic formation of α-aminomuconic acid from 3-hydroxyanthranilic acid, J. Biol. Chem. 240, 740-749 (1965).
43. A.H. Mehler, E.L. May, Studies with carboxyl-labelled 3-hydroxyanthranilic and picolinic acid in vivo and in vitro, J. Biol. Chem. 223, 449-455 (1956).
44. L.M. Henderson, B.B. Ramasarma, B.C. Johnson, Quinolinic metabolism IV. Urinary excretion by man and other mammals as affected by the ingestion of tryptophan, J. Biol. Chem. 181, 731-738 (1949)
45. P. Feigelson and O. Greengard, A microsomal iron-porphyrin activator of rat liver tryptophan pyrrolase, J. Biol. Chem. 236, 153-157 (1961).
46. G. Allegri, C. Costa, A. De Antoni, F. Baccichetti, S. Vanzan, Effect of psoralen-induced photodermatitis on tryptophan metabolism in guinea pigs, Il Farmaco Ed. Sci. 36, 557-564 (1981).
47. T. Shimizu, S. Nomiyama, F. Hirata and O. Hayaishi, Indoleamine 2,3-dioxygenase Purification and some properties, J. Biol. Chem. 253, 4700-4706 (1978).
48. M.R. Mawal and D.R. Deshmukh, α-Aminoadipate aminotransferase and kynurenine aminotransferase activities from rat kidney. Evidence for separate identity, J. Biol. Chem. 266, 2573-2575 (1991).
49. O. Hayaishi, Kynurenine hydroxylase, Methods Enzymol. 5, 807-809 (1962).
50. A. Saran, Properties and partial purification of kynureninase, Biochem J. 70, 182-188 (1958).
51. A. Bertazzo, E. Ragazzi, M. Biasiolo, C.V.L. Costa, G. Allegri, Enzyme activities involved in tryptophan metabolism along the kynurenine pathway in rabbits, Biochim. Biophys. Acta 1527, 167-175 (2001).
52. M. Mason, The kynurenine transaminase of rat kidney, J. Biol. Chem. 211, 839-844 (1954).
53. A.H. Mehler, Formation of picolinic and quinolinic acids following enzymatic oxidation of 3-hydroxyanthranilic acid, J. Biol. Chem. 218, 241-254 (1956).
54. W.A. Koontz, R. Shiman, Beef kidney 3-hydroxyanthranilic acid oxygenase. Purification, characterization, and analysis of the assay, J. Biol. Chem. 251, 368-377 (1976).
55. C. Beauchamp, I. Fridovich, Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels, Anal. Biochem. 44, 276-287 (1971).
56. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall, Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
57. A. De Antoni, G. Allegri, C. Costa, S. Vanzan, A. Bertolin, N. Carretti, V. Zanardo, Total and free tryptophan levels in serum of newborn infants. Relationships with serotonin and nicotinic acid pathways, Acta Vitaminol. Enzymol. 2, 17-20 (1980).
58. W.D. Denckla and H.H. Dewey, The determination of tryptophan in plasma, liver, and urine, J. Lab. Clin. Med. 69, 160-169 (1967).
59. G.E. Werner-Felmayer, E.R. Werner, D. Fuchs, A. Hansen, G. Reibnegger, H. Wachter, Characteristics of interferon induced tryptophan metabolism in human cells in vitro, Biochim. Biophys. Acta 1012, 140-147 (1989).
60. J.M. Carlin, E.C. Borden, P.M. Sondel, G.I. Byrne, Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes, J. Leukocyte Biol. 45, 29-34 (1989).
61. A. De Antoni, N. Carretti, C. Costa, N. D'Antona, A. Bertolin, G. Allegri, Serum total and free tryptophan concentration in mothers at delivery and in their newborn babies, Giorn. It. Chim. Clin. 5, 71-77 (1980).
62. H. Schrocksnadel, G. Baier-Bitterlich, O. Dapunt, H. Wachter, D. Fuchs, Decreased plasma tryptophan in pregnancy, Obstet. Gynecol. 88, 47-50 (1996).
63. Y. Suzuki, M.A. Orellana, R.D. Schreiber, J.S. Remington, Interferon-γ: the major mediator of resistance against Toxoplasma gondii, Science 240, 516-518 (1988).
64. E.R. Pfefferkorn, Interferon blocks the growth of Toxoplasma gondii in human fibroblast by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci. USA 81, 908-912 (1984).
65. G.I. Byrne, L.K. Lehmann, G.J. Landry, Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells, Infect. Immun. 53, 347-351 (1986).
66. J.M. Carlin, E.C. Borden, P.M. Sondel, G.I. Byrne, Biologic response modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures, J. Immunol. 139, 2414-2418 (1987).
67. A. Habara-Ohkubo, T. Shirahata, O. Takikawa, R. Yoshida, Estabishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase, Infect. Immun. 61, 1810-1813 (1993).
68. T.M. Aune, S.-L. Pogue, Inhibition of tumor cell growth by interferon-γ is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide, J. Clin. Invest. 84, 863-875 (1989).
69. R. Yoshida, O. Takikawa, H. Yasui, O. Hayaishi, and K. Yasuhira, Role of indoleamine 2,3-dioxygenase in the defence mechanism against tumor growth, in: Progress in Tryptophan and Serotonin Research, edited by W. de Gruyter (Plenum Press, New York, 1984), pp. 513-516.
70. S. Fujigaki, K. Saito, M. Takemura, H. Fujii, H. Wada, A. Noma, M. Seishima, Species differences in L-tryptophan-kynurenine pathway metabolism. Quantification of anthranilic acid and its related enzymes, Arch. Biochem. Biophys. 358, 329-335 (1998).
71. A. De Antoni, C. Costa, F. Baccichetti, E.L. Cardin de Stefani, S. Vanzan, G. Allegri, Enzyme activities and metabolites along the kynurenine pathway in mice with Harding-Passey melanoma, Acta Vitaminol. Enzymol. 5, 83-87 (1983).
72. C. Costa, A. De Antoni, F. Baccichetti, M. Biasiolo, G. Allegri, Metabolites and enzyme activities involved in tryptophan metabolism in two different strains of mouse, It. J. Biochem. 33, 319-324 (1984).
73. D.A. Bender and G.M. McCreanor, The preferred route of kynurenine metabolism in the rat, Biochim. Biophys. Acta 717, 56-60 (1982).